Menu

Philip Mitchell has provided health regulatory counsel to a range of industry clients, including hospital systems, provider practice groups, management services organizations, clinical laboratories, managed care organizations and health insurers, pharmaceutical and biologic manufacturers, and specialty pharmacies, other proprietary and nonprofit healthcare enterprises, and investment firms.

Download full bio 

Experience

  • Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion 

  • General Catalyst Leads Eleanor Health’s $50 Million Series C  

  • Biote Agrees to Combine With SPAC Haymaker Acquisition Corp. III 

  • Arena Pharmaceuticals Agrees to Sell to Pfizer for $6.7 Billion 

  • Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II 

  • View all

Education

  • University of Virginia School of Law
    JD, 1986

  • Princeton University, Woodrow Wilson School
    MPA, 1987

  • The Wharton School of the University of Pennsylvania
    BS, 1982

  • University of Pennsylvania
    BA, 1982


Admissions & Credentials

New Jersey

New York

Pennsylvania

Memberships

  • American Bar Association

  • American Health Lawyers Association